Neurodegenerative diseases, like Alzheimer's disease (AD), are characterized by the accumulation of tau aggregates, leading to neuronal dysfunction and cognitive decline. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.